Home
  About Us
  Management
  Operations
  History
  Membership
  Research
  Teaching
  Seminars
  CNS Awarded Prizes
  Reports
  News
  Neuropursuit Championship
  25th Anniversary
  Contact us
SANI - South Australian
Neuroscience Institute
FUSA crestFMC logo
School of Medicine Contact Search

Cardiovascular Neuroscience Laboratory

Research Projects

Chronic heart failure induces changes in autonomic nerve pathways in the paraventricular nucleus of the hypothalamus
The paraventricular nucleus of the hypothalamus (PVN) plays an important role in cardiovascular control. It integrates information from many visceral afferents and influences three major central processing systems, the endocrine, neuroendocrine and autonomic nervous systems. the interactions between these systems is unbalanced in chronic heart failure (CHF), a major health problem in developed nations that results from the heart’s inability to pump blood effectively. The PVN compensates for the failing heart through alterations in hormone release from the pituitary and in the activity of central circuits that control sympathetic outflow, particularly cardiac sympathetic outflow. These effects suggest that autonomic nerve pathways in the PVN may be altered in CHF. To address this hypothesis, we performed left coronary ligation surgery in rats, which is known to produce the symptoms of CHF in about 1/3 of surviving rats after 6-7 weeks. Rats were perfused at that time and sections of hypothalamus were stained immunohistochemically for corticotrophin releasing factor (CRF), vasopressin (VP), nitric oxide synthase (NOS), enkephalin (ENK) and pro-enkephalin (pro-ENK). Numbers of immunoreactive neurons were counted in rats with CHF (i.e., rats with infarcts occupying more than 40% of the left ventricle) and in sham-operated control rats. CRF-immunoreactive neurons were more numerous in the PVN of rats with CHF than in control rats (205 ± 108 vs 87 ± 16, mean + SD; p<0.05, n=6 rats/group) as were VP-immunoreactive neurons (289 ± 36 vs 232 ± 42; p<0.05, n=5 rats/group). There was a trend towards a decrease in the number of NOS-positive neurons in CHF compared to control rats (689 ± 76 vs 866 ± 150; p=0.07, n=5/group), supporting previously published studies. Neurons containing ENK- or pro-ENK-immunoreactivity were found lateral to, not within, the PVN; and the numbers of ENK- and pro-ENK-immunoreactive neurons were similar rats with CHF and sham-operated controls. These data show that CHF induces changes in the numbers of some neurochemically-identified populations of PVN neurons but not in other populations. The populations of PVN neurons that change in response to CHF are likely to be involved in adaptive mechanisms that attempt to compensate for the failing heart.

Nitric oxide synthase immunoreactivity in sympathetic preganglionic neurons
Sympathetic preganglionic neurons (SPN) are cholinergic and therefore all SPN contain choline acetyltransferase (ChAT). Several other neurochemical markers also occur in SPN and one of the most prominent is nitric oxide synthase (NOS). The proportion of SPN showing NOS-immunoreactivity has been reported to vary with blood pressure level and published data suggest that the occurrence of NOS in SPN may also correlate with the target that they innervate. To investigate these relationships, we first evaluated peroxidase immunolabelling for ChAT plus NOS in spinal cord segments T1-L2 from normotensive Sprague-Dawley rats (SD) and assessed NOS-immunofluorescence in SPN retrogradely labelled with cholera toxin B subunit from the adrenal medulla (AM), or superior cervical (SCG), coeliac (CG) or major pelvic (MPG) ganglia. We also compared the distributions and numbers of NOS-positive and NOS-negative/ChAT-positive lateral horn neurons between SD and spontaneously hypertensive rats (SHR). In SD, rostrocaudal, dorsoventral and mediolateral differences occurred in the distributions of NOS-positive and NOS-negative/ChAT-positive neurons in the intermediolateral cell column (IML) whereas the two groups were similarly distributed throughout the central autonomic area (CAA). Amongst the four retrogradely-labelled populations of SPN, the percentages showing NOS-immunoreactivity differed (CG-projecting, 54.8 +0.7%; SCG-projecting, 75.3 +1.2%; MPG-projecting, 89 +1.1% and AM-projecting, 98.6 +0.2%). Within each retrogradely labelled group of SPN, the NOS-positive proportion also varied with subnuclear location (e.g., 25.5 +4.0% of CG-projecting SPN in the CAA vs. 82.7 +7.6% of CG-projecting SPN in the dorsolateral funiculus). In SHR, the overall distributions of NOS-positive and NOS-negative/ChAT-positive neurons, their morphologies and their numbers in T9-11 were the same as in SD. These results show that the expression of NOS within SPN varies depending on the target that they innervate and also on their subnuclear location. Our data do not support previously published data suggesting that there are anatomical differences between nitric oxide-synthesizing SPN in normotensive and hypertensive rats.

Innervation of sacral autonomic neurons by axons containing corticotropin releasing factor
Brain neurons immunoreactive for corticotropin releasing factor (CRF) are involved in regulating micturition. Intrathecal administration of a CRF antagonist affects voiding and CRF-containing axons occur in the sacral parasympathetic nucleus, which contains parasympathetic preganglionic neurons (PPN) controlling bladder function. To determine which sacral spinal neurons are innervated by CRF axons , we activated spinal neurons by evoking micturition reflexes with continuous infusions of saline in anesthetized male Sprague Dawley rats and perfused at 2 hours after the commencement of the infusion. Transverse sections of L5-S2 were stained with a black peroxidase reaction product to reveal immunoreactivity for CRF and Fos, a marker of neuronal activation. A brown product was used to localize immunoreactivity for choline acetyltransferase (ChAT), nitric oxide synthase (NOS) or cholera toxin B subunit (CTB) retrogradely transported from the major pelvic ganglion, all of which mark PPN. Neurons with Fos-immunoreactive nuclei were concentrated in the sacral parasympathetic nucleus and Lissauer’s tract. Fos-positive neurons also occurred in lamina X above the central canal. Most Fos-positive neurons in the sacral parasympathetic nucleus lacked ChAT, NOS or CTB-immunoreactivity, indicating that they were not PPN. CRF axons targeted the region of the sacral parasympathetic nucleus containing PPN and close appositions occurred on Fos-positive neurons immunoreactive for markers of PPN. CRF axons only occasionally approached Fos only neurons that lay dorsal to the PPN or occurred in Lissauer’s tract. CRF axons were rare in lamina X above the central canal. These results suggest that CRF axons preferentially innervate PPN rather than non-preganglionic neurons that are involved in regulating bladder activity.

Activation of micturition-related sacral spinal neurons differs between rats with normal and overactive bladder
Non-voiding contractions are a hallmark of overactive bladder (OAB), which affects 10-15% of the population in developed countries. Spontaneously hypertensive rats (SHR) have non-voiding contractions and reduced bladder capacity; and pharmacological studies suggest that spinal mechanisms are involved in these changes in micturition. We investigated whether micturition-related neurons in the sacral parasympathetic nucleus differed between female rats with normal and overactive bladders. We induced Fos-immunoreactivity by evoking micturition reflexes through bladder infusions of saline under urethane anaesthesia while bladder pressure was being continuously recorded. Control rats were not infused. Segments L5-S2 from pairs of infused and control rats were cut transversely and immunoreactivity for Fos plus choline acetyltransferase (ChAT) were localized immunocytochemically. Neurons showing immunoreactivity for Fos, ChAT or Fos+ChAT were counted in each rat. Infused Sprague Dawley (SD) female rats (n=6) had few non-voiding contractions whereas 3/6 infused SHR females and 4/6 infused Wistar-Kyoto (WKY) had many non-voiding contractions. Large numbers of Fos-immunoreactive neurons were present in all infused SD. In infused SHR and WKY, Fos-positive neurons were very variable in number but consistently less numerous than in infused SD. Control SD rats had many fewer Fos-immunoreactive neurons than infused SD rats. In contrast, in SHR and WKY, the numbers of Fos-positive neurons in pairs of infused and control rats were often similar. In infused rats that had more Fos-positive neurons than control rats, Fos-positive neurons occurred mainly in and dorsal to the parasympathetic nucleus; double-labelled neurons were concentrated in the sacral parasympathetic nucleus and around the central canal. Statistical analysis showed that the number of Fos-positive PPN was inversely correlated with the number of voiding and non-voiding contractions that occurred in the first 30 minutes of the infusion period. These findings indicate that neural control of micturition differs between rats with OAB and rats with normal bladder function. Furthermore, since many WKY appear to have OAB, they are not appropriate controls for studies on bladder function in SHR.

 

< Back to Cardiovascular Neuroscience Home Page >

 

Updated March 24, 2011